ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0382

Preventative Health Screening Practices Among 666 Women with Systemic Rheumatic Diseases from the Hospital for Special Surgery Rheumatology Women’s Reproductive Health and Wellness Cohort: A Cross-Sectional Analysis

Sandhya shri Kannayiram1, Amaya Smole2, Lucy Masto3, Yongjay Kim4, Neha Nagpal1, Naiva Manuela Piatchou Donfack1, Deanna Jannat-Khah1, Lisa Mandl1, Sarah Lieber1, Caroline Siegel1, Michael Lockshin5, Lisa Sammaritano1 and Medha Barbhaiya1, 1HOSPITAL FOR SPECIAL SURGERY, New york, NY, 2Hospital for Special Surgery, Brooklyn, NY, 3Hospital for Special Surgery, San Francisco, CA, 4Hospital for Special Surgery, Englewood Cliffs, NJ, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: ACR Convergence 2025

Keywords: Access to care, health behaviors, prevention, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0357–0386) Patient Outcomes, Preferences, & Attitudes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Timely preventative health screenings in women with systemic rheumatic diseases (SRDs), especially those with other chronic conditions or who are on immunosuppressive therapy, may improve outcomes through early detection. This study aimed to identify demographic, lifestyle, disease-related, and healthcare utilization factors associated with delayed preventative health screenings in this population.

Methods: We included women aged 18-65 evaluated at Hospital for Special Surgery (HSS) by a rheumatologist ≥2 times who enrolled in the HSS Rheumatology Women’s Reproductive Health and Wellness Cohort between 12/2022- 5/2024 and completed a standardized questionnaire on their preventative health screening status. Patients reported being “due or overdue” for six screenings: colon, breast, cervical, and skin cancers; bone density; and retinal (eye) toxicity screening. We evaluated the degree of delay and the reasons for delay. Descriptive analyses compared demographics, lifestyle factors, SRD status, medication use, and healthcare utilization for patients “due/overdue” versus those not due/overdue for the screenings. Multivariable logistic regression analyzed factors associated with being due/overdue for each screening.

Results: Among 666 women included in this cross-sectional analysis, increased age was associated with being due/overdue for colon, breast, and skin cancer, as well as bone density screening, and patients with ‘other’ or Black race, but not White race were more frequently due/overdue for bone density screenings (Table 1). Hispanic versus non-Hispanic women were more frequently due/overdue for breast (21% vs. 11%) and eye toxicity screenings (20% vs. 11%). Ever smokers were also more likely to be due/overdue for breast, cervical, skin cancer, bone density, and eye toxicity screenings than non-smokers, and SRD status was significantly different only for eye toxicity screenings(Table 1).In multivariable analyses, factors associated with being due/overdue for a particular screening test included: increased age (OR=1.04, 95%CI 1.02–1.07) for colon cancer; increased age (OR=1.04, 95%CI 1.02–1.06), Hispanic ethnicity (OR=2.40, 95% CI 1.27–4.47), and < 1/year gynecology visits (OR=2.03, 95% CI 1.2–3.3) for breast cancer; ever smoking (OR=1.96, 95% CI 1.14-3.35) and < 1/year gynecology visits (OR=3.70, 95% CI 2.2–6.1) for cervical cancer; increasing age (OR=1.06, 95%CI 1.03–1.09) and ‘Other’ vs. white race (OR=4.36, 95% CI 2.13-8.87] for bone density; and ever smoking(OR=2.57, 95 % CI 1.37-4.81), CTD status (OR=2.30, 95% CI 1.3–4.03) and unemployment(OR=1.97, 95% CI 1.3–4.8) for eye toxicity screening (Table 2). Degrees of self-reported delays were most typically < 1 year (Figure). The most common reasons for delay were forgetfulness and scheduling difficulty (data not shown).

Conclusion: Preventative health screening delays in a cohort of women with SRDs were influenced by age, Race, Ethnicity, smoking history, CTD diagnosis, employment status, and infrequent gynecology visits. Targeted strategies are needed to improve adherence to suggested screenings and thereby reduce health risks in this vulnerable population.

Supporting image 1Table 1. Demographic, Socioeconomic, Lifestyle, Disease, and Health Utilization Factors in 666 women with Systemic Rheumatic Diseases Enrolled in the Rheumatology Women’s Reproductive Health and Wellness Cohort between 2022 and 2024, by their Preventative Health Screening Status for Six Screening Evaluations

Supporting image 2Table 2. Logistic Regression Results Estimating the Association of Demographic, Medication, and Healthcare Utilization Factors with Being Due/Overdue for a Preventative Health Screening Study Among 666 women with Systemic Rheumatic Diseases enrolled in the Rheumatology Women’s Reproductive Health and Wellness Cohort between 2022 and 2024

Supporting image 3Figure: Degree of Delay in Health Screenings Among 666 Women with Systemic Rheumatic Diseases Enrolled in the

Rheumatology Women’s Reproductive Health and Wellness Cohort between 2022 -2024


Disclosures: S. Kannayiram: None; A. Smole: None; L. Masto: None; Y. Kim: None; N. Nagpal: None; N. Piatchou Donfack: EMD Serono, 3; D. Jannat-Khah: AstraZeneca, 11, CytoDyn, 11; L. Mandl: ACP, 12, Associate Editor Annals of Internal Medicine, Wolters, 9; S. Lieber: None; C. Siegel: None; M. Lockshin: None; L. Sammaritano: None; M. Barbhaiya: None.

To cite this abstract in AMA style:

Kannayiram S, Smole A, Masto L, Kim Y, Nagpal N, Piatchou Donfack N, Jannat-Khah D, Mandl L, Lieber S, Siegel C, Lockshin M, Sammaritano L, Barbhaiya M. Preventative Health Screening Practices Among 666 Women with Systemic Rheumatic Diseases from the Hospital for Special Surgery Rheumatology Women’s Reproductive Health and Wellness Cohort: A Cross-Sectional Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/preventative-health-screening-practices-among-666-women-with-systemic-rheumatic-diseases-from-the-hospital-for-special-surgery-rheumatology-womens-reproductive-health-and-wellness-cohort-a-c/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/preventative-health-screening-practices-among-666-women-with-systemic-rheumatic-diseases-from-the-hospital-for-special-surgery-rheumatology-womens-reproductive-health-and-wellness-cohort-a-c/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology